| dc.contributor.author | Bonet Martínez, Fernando | |
| dc.contributor.author | Campuzano, Oscar | |
| dc.contributor.author | Córdoba Caballero, José | |
| dc.contributor.author | Alcalde, Mireia | |
| dc.contributor.author | Sarquella-Brugada, Georgia | |
| dc.contributor.author | Braza-Boïls, Aitana | |
| dc.contributor.author | Brugada, Ramón | |
| dc.contributor.author | Hernandez-Torres, Francisco | |
| dc.contributor.author | Quezada-Feijoó, Maribel | |
| dc.contributor.author | Ramos, Mónica | |
| dc.contributor.author | Mangas Rojas, Alipio | |
| dc.contributor.author | Ranea, Juan A.G. | |
| dc.contributor.author | Toro Cebada, Rocío | |
| dc.contributor.other | Medicina | es_ES |
| dc.date.accessioned | 2025-04-02T09:05:48Z | |
| dc.date.available | 2025-04-02T09:05:48Z | |
| dc.date.issued | 2024-08-09 | |
| dc.identifier.issn | 2227-9059 | |
| dc.identifier.uri | http://hdl.handle.net/10498/36039 | |
| dc.description.abstract | Arrhythmogenic cardiomyopathy is an inherited entity characterized by irregular cell–cell
adhesion, cardiomyocyte death and fibro-fatty replacement of ventricular myocytes, leading to malignant
ventricular arrythmias, contractile dysfunction and sudden cardiac death. Pathogenic variants
in genes that encode desmosome are the predominant cause of arrhythmogenic cardiomyopathy.
Moreover, signalling pathways such as Wnt/ß-catenin and transforming growth factor-β have been
involved in the disease progression. However, still little is known about the molecular pathophysiological
mechanisms that underlie arrhythmogenic cardiomyopathy pathogenesis. We used mRNA
and small RNA sequencing to analyse the transcriptome of health and arrhythmogenic cardiomyopathy
of autopsied human hearts. Our results showed 697 differentially expressed genes and eight
differentially expressed miRNAs. Functional enrichment revealed mitochondrial respiratory-related
pathways, impaired response to oxidative stress, apoptotic signalling pathways and inflammatory response-related and extracellular matrix response pathways. Furthermore, analysis of the miRNA–
mRNA interactome identified eleven negatively correlated miRNA-target pairs for arrhythmogenic
cardiomyopathy. Our finding revealed novel arrhythmogenic cardiomyopathy-related miRNAs with
important regulatory function in disease pathogenesis, highlighting their value as potential key
targets for therapeutic approaches. | es_ES |
| dc.format | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | MDPI | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.source | Biomedicines, Vol. 12, Núm. 8, 2024 | es_ES |
| dc.subject | arrhythmogenic cardiomyopathy | es_ES |
| dc.subject | sudden cardiac death | es_ES |
| dc.subject | RNA sequencing | es_ES |
| dc.subject | microRNA | es_ES |
| dc.subject | miRNA–mRNA | es_ES |
| dc.title | Role of miRNA–mRNA Interactome in Pathophysiology of Arrhythmogenic Cardiomyopathy | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.3390/biomedicines12081807 | |
| dc.type.hasVersion | VoR | es_ES |